Antimony potassium tartrate
Agent Name
Antimony potassium tartrate
Formula
C8-H4-O12-Sb2.3H2-O.2K
Synonyms
Antimonate (2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2,O3,O4))di-, dipotassium, trihydrate, stereoisomer; Antimonate(2)-, bis(mu-tartrato(4-))di-, dipotassium, trihydrate; Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O(sup 1),O(sup 2):O(sup 3),O(sup 4)))-di-, dipotassium, trihydrate, stereoisomer; Antimonyl potassium tartrate; Dipotassium bis(mu-(L-(+)-tartrato(4-)))diantimonate(2-) trihydrate; Emetique [French]; Potassium antimony tartrate; Potassium antimonyl d-tartrate; Potassium antimonyl tartrate; Potassium antimonyltartrate; Tartar emetic; Tartaric acid, antimony potassium salt; Tartarized antimony; Tartox; Tartrate antimonio-potassique [French]; Tartrated antimony; [ChemIDplus] UN1551
Category
Metalloid Compounds (Antimony)
Description
Transparent odorless solid; Efflorescing on exposure to air; Or white solid; [Hawley] Crystalline solid; [MSDSonline]
Sources/Uses
Used as mordant in the textile and leather industries, a pesticide (snails and insects), and a medication (schistosomicides and veterinary parasiticides) [HSDB]
Comments
When used as an IV medication, side effects included nervous complaints, cardiac arrhythmias, liver and kidney injury, and death; The minimum fatal dose for humans is 130 mg with a report of a survival after 15,000 mg; May produce pustular eruptions if applied to skin for long periods; Oral LD50 (mouse) = 600 mg/kg; [HSDB] A skin, eye, and respiratory tract irritant; [CAMEO] An irritant; Effects in high-dose animal studies include acute renal failure and acute and hepatocellular necrosis; [MSDSonline] See "Antimony" and linked occupational diseases.
TLV (ACGIH)
0.5 mg/m3, as Sb
PEL (OSHA)
0.5 mg/m3, as Sb
IDLH (NIOSH)
50 mg/m3, as Sb
Hepatotoxin
Hepatoxic (a) from occupational exposure (secondary effect) or (b) in animal studies or in humans after ingestion
IARC Carcinogen
Probable (2a)
Processes
Industrial Processes with risk of exposure: